Some researchers question conclusion in Nature study that stem cells can be created without destroying embryos

NewsGuard 100/100 Score

Some human embryonic stem cell researchers recently have questioned whether methods used in a study published in the Aug. 24 edition of the journal Nature were sufficient to conclude that human embryonic stem cells could be created without destroying the embryo, the Wall Street Journal reports (Hamilton/Regalado, Wall Street Journal, 9/5).

In the study, Robert Lanza, medical director of Worcester, Mass.,-based Advanced Cell Technology, and colleagues described the technique as removing a single cell -- known as a blastomere -- from a three-day-old embryo with eight to 10 cells and using a biochemical process to create embryonic stem cells from the blastomere. Researchers removed 91 blastomeres from 16 thawed embryos donated by fertility clinic patients and found that more than half of the blastomeres began to multiply and that in two cases the blastomeres became embryonic stem cells. The method of removing a cell from the embryo is based on preimplantation genetic diagnosis, or PGD, which usually is used to test the cell for genetic deficiencies. At the time the Nature article was published, Lanza said the research destroyed some of the embryos used but single-cell extractions that leave the embryo unharmed should be feasible in the future (Kaiser Daily Women's Health Policy Report, 9/1). Although the blastomeres removed by the researchers from the embryos were separate, multiple blastomeres shared a common fluid in the same laboratory dish, which could have allowed them to exchange proteins and other factors linked to growth, according to the Journal. "One of the flaws in this paper is that it draws conclusions that they don't really have the data to prove," Barry Behr, director of Stanford University's IVF Laboratories, said, adding, "The sort of leaps of faith here are a little too big to leap." Lanza said ACT researchers have successfully grown a blastomere with its parent embryo for about one day following separation, adding that it should be possible to culture blastomeres from separate embryos in the same lab dish (Wall Street Journal, 9/5).

Nature Changes

Nature last week corrected wording in a news release it had distributed in advance of the study's release after Richard Doerflinger of the United States Conference of Catholic Bishops in an e-mail wrote that the results presented in the release were misleading. According to Doerflinger, the release did not make it clear that the embryos used in the research did not survive in the experiments. Nature officials on Thursday said they plan to change the study to further clarify that none of the embryos used survived the experiment (Kaiser Daily Women's Health Policy Report, 9/1). Lanza on Friday said he had not seen the Nature release before it was published (Wade, New York Times, 9/2).


Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Discovery of new vascular cell type may pave way for novel strategies to treat cardiovascular diseases